Sunovion Pharmaceuticals Director of Finance Salaries in Boulder | Comparably
Sunovion Pharmaceuticals Inc. engages in discovering, developing, and commercializing therapeutic products for patients suffering from read more
EMPLOYEE
PARTICIPANTS
6
TOTAL
RATINGS
175

Sunovion Pharmaceuticals Director of Finance Salaries in Boulder

The average Sunovion Pharmaceuticals Director of Finance in Boulder earns an estimated $147,213 annually. Sunovion Pharmaceuticals' Director of Finance compensation is $14,803 less than the US average for a Director of Finance.

In Boulder, The Finance Department at Sunovion Pharmaceuticals earns $2,374 more on average than the Customer Support Department.

Last updated 3 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$147,213
Average Compensation
$147,213
avg. base

Director of Finance Salaries at Sunovion Pharmaceuticals

In Boulder, Directors of Finance earn $46,386 more than Accounting Managers.

Accounting Manager
$101k*
Senior Accountant
$90k*
Financial Analyst
$80k*
Accountant
$63k*
Business Analyst
$63k*
* estimated salary

Compensation at Sunovion Pharmaceuticals by Department

In Boulder, The Finance Department averages $2,374 more than the Customer Support Department, and $22,932 less than the Business Development Department

Business Development
$98,433 Avg. total comp.
+$23k
Finance
$75,501 Avg. total comp.
Customer Support
$73,127 Avg. total comp.
-$2k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Sunovion Pharmaceuticals reported making $151,477, while the average male Director of Finance at similar sized companies reported making $182,079.

Director of Finance Compensation by Ethnicity (All Companies)

The average Hispanic or Latino Director of Finance at companies similar size to Sunovion Pharmaceuticals reported making $205,000, while the average Caucasian Director of Finance at similar sized companies reported making $161,795.

How Directors of Finance at Sunovion Pharmaceuticals Rate Their Compensation

The majority of Directors of Finance at Sunovion Pharmaceuticals believe they're not compensated fairly. 67% of Directors of Finance at Sunovion Pharmaceuticals say they receive annual bonuses, and the vast majority (80%) are satisfied with their benefits. See more compensation ratings at Sunovion Pharmaceuticals

×
Rate your company